Dupilumab for Eosinophilic Gastritis and Severe Asthma
Author Information
Author(s): Takeshige Tomohito, Koyama Ryo, Motomura Hiroaki, Okajima Akifumi, Nishioki Toshihiko, Watanabe Junko, Yae Toshifumi, Kido Kenji, Takahashi Kazuhisa
Primary Institution: Juntendo University
Hypothesis
Can dupilumab effectively treat eosinophilic gastritis in patients with severe asthma?
Conclusion
Dupilumab may be an effective treatment option for eosinophilic gastritis and severe asthma.
Supporting Evidence
- The patient's eosinophilic gastritis symptoms improved after starting dupilumab.
- Dupilumab also improved the patient's asthma symptoms and control.
- No adverse events were reported following the treatment.
Takeaway
A woman with stomach pain and asthma got better after taking a medicine called dupilumab, which helped both her conditions.
Methodology
Case report detailing the treatment of a patient with eosinophilic gastritis and severe asthma using dupilumab.
Limitations
This study reports only one case, and biopsies were not performed on other parts of the gastrointestinal tract.
Participant Demographics
A 35-year-old woman with a history of asthma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website